Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 330

1.

The significance of antral follicle size prior to stimulation in predicting ovarian response in a multiple dose GnRH antagonist protocol.

Lai Q, Chen C, Zhang Z, Zhang S, Yu Q, Yang P, Hu J, Wang CY.

Int J Clin Exp Pathol. 2013;6(2):258-66. Epub 2013 Jan 15.

2.

Predictive value of anti-müllerian hormone, follicle-stimulating hormone and antral follicle count on the outcome of ovarian stimulation in women following GnRH-antagonist protocol for IVF/ET.

Tsakos E, Tolikas A, Daniilidis A, Asimakopoulos B.

Arch Gynecol Obstet. 2014 Dec;290(6):1249-53. doi: 10.1007/s00404-014-3332-3. Epub 2014 Jul 8.

PMID:
25001569
3.
4.

The use of anti-Müllerian hormone and antral follicle count to predict the potential of oocytes and embryos.

Majumder K, Gelbaya TA, Laing I, Nardo LG.

Eur J Obstet Gynecol Reprod Biol. 2010 Jun;150(2):166-70. doi: 10.1016/j.ejogrb.2010.02.029. Epub 2010 Mar 11.

PMID:
20223579
5.

Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients.

Arce JC, La Marca A, Mirner Klein B, Nyboe Andersen A, Fleming R.

Fertil Steril. 2013 May;99(6):1644-53. doi: 10.1016/j.fertnstert.2012.12.048. Epub 2013 Feb 5.

6.

[Prediction of ovarian reserve, poor response and pregnancy outcome based on basal antral follicle count and age in patients undergoing in vitro fertilization-embryo transfer].

Chen SL, Xia R, Chen X, Luo YQ, Wang LL, Wu YQ, Shi XY, Zheng HY.

Nan Fang Yi Ke Da Xue Xue Bao. 2011 Apr;31(4):572-7. Chinese.

7.

Antral follicle count is a significant predictor of livebirth in in vitro fertilization cycles.

Maseelall PB, Hernandez-Rey AE, Oh C, Maagdenberg T, McCulloh DH, McGovern PG.

Fertil Steril. 2009 Apr;91(4 Suppl):1595-7. doi: 10.1016/j.fertnstert.2008.11.001. Epub 2008 Dec 18.

PMID:
19100533
8.

Efficacy of recombinant human follicle-stimulating hormone in improving oocyte quality in assisted reproductive techniques.

Cheon KW, Byun HK, Yang KM, Song IO, Choi KH, Yoo KJ.

J Reprod Med. 2004 Sep;49(9):733-8.

PMID:
15493565
9.

Initiation of ovarian stimulation independent of the menstrual cycle: a case-control study.

Buendgen NK, Schultze-Mosgau A, Cordes T, Diedrich K, Griesinger G.

Arch Gynecol Obstet. 2013 Oct;288(4):901-4. doi: 10.1007/s00404-013-2794-z. Epub 2013 Apr 3.

PMID:
23545834
10.
11.

Predictive factors for ovarian response in a corifollitropin alfa/GnRH antagonist protocol for controlled ovarian stimulation in IVF/ICSI cycles.

Oehninger S, Nelson SM, Verweij P, Stegmann BJ.

Reprod Biol Endocrinol. 2015 Oct 31;13:117. doi: 10.1186/s12958-015-0113-1.

12.
13.

Impact of repeated antral follicle counts on the prediction of poor ovarian response in women undergoing in vitro fertilization.

Bancsi LF, Broekmans FJ, Looman CW, Habbema JD, te Velde ER.

Fertil Steril. 2004 Jan;81(1):35-41.

PMID:
14711542
14.

High ovarian response does not jeopardize ongoing pregnancy rates and increases cumulative pregnancy rates in a GnRH-antagonist protocol.

Fatemi HM, Doody K, Griesinger G, Witjes H, Mannaerts B.

Hum Reprod. 2013 Feb;28(2):442-52. doi: 10.1093/humrep/des389. Epub 2012 Nov 7. Erratum in: Hum Reprod. 2014 Sep;29(9):2074-5.

PMID:
23136144
15.

The clinical analysis of poor ovarian response in in-vitro-fertilization embryo-transfer among Chinese couples.

Zhen XM, Qiao J, Li R, Wang LN, Liu P.

J Assist Reprod Genet. 2008 Jan;25(1):17-22. doi: 10.1007/s10815-007-9187-9. Epub 2008 Jan 18.

16.

Predictive factors of ovarian response and clinical outcome after IVF/ICSI following a rFSH/GnRH antagonist protocol with or without oral contraceptive pre-treatment.

Andersen AN, Witjes H, Gordon K, Mannaerts B; Xpect investigators.

Hum Reprod. 2011 Dec;26(12):3413-23. doi: 10.1093/humrep/der318. Epub 2011 Sep 27.

PMID:
21954280
17.

GnRH antagonist and letrozole co-treatment in diminished ovarian reserve patients: a proof-of-concept study.

Olgan S, Humaidan P.

Reprod Biol. 2017 Mar;17(1):105-110. doi: 10.1016/j.repbio.2017.01.006. Epub 2017 Feb 4.

PMID:
28173995
18.

Synchronization of ovarian stimulation with follicle wave emergence in patients undergoing in vitro fertilization with a prior suboptimal response: a randomized, controlled trial.

Baerwald A, Anderson P, Yuzpe A, Case A, Fluker M.

Fertil Steril. 2012 Oct;98(4):881-7.e1-2. doi: 10.1016/j.fertnstert.2012.06.051. Epub 2012 Jul 20.

PMID:
22819187
19.

Anti-Müllerian hormone versus antral follicle count for defining the starting dose of FSH.

Lan VT, Linh NK, Tuong HM, Wong PC, Howles CM.

Reprod Biomed Online. 2013 Oct;27(4):390-9. doi: 10.1016/j.rbmo.2013.07.008. Epub 2013 Jul 23.

PMID:
23953069
20.

Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.

Nardo LG, Gelbaya TA, Wilkinson H, Roberts SA, Yates A, Pemberton P, Laing I.

Fertil Steril. 2009 Nov;92(5):1586-93. doi: 10.1016/j.fertnstert.2008.08.127. Epub 2008 Oct 18.

PMID:
18930213

Supplemental Content

Support Center